IL136368A0 - Novel compounds - Google Patents

Novel compounds

Info

Publication number
IL136368A0
IL136368A0 IL13636898A IL13636898A IL136368A0 IL 136368 A0 IL136368 A0 IL 136368A0 IL 13636898 A IL13636898 A IL 13636898A IL 13636898 A IL13636898 A IL 13636898A IL 136368 A0 IL136368 A0 IL 136368A0
Authority
IL
Israel
Prior art keywords
novel compounds
novel
compounds
Prior art date
Application number
IL13636898A
Other languages
English (en)
Original Assignee
Astrazeneca Uk Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Uk Ltd filed Critical Astrazeneca Uk Ltd
Publication of IL136368A0 publication Critical patent/IL136368A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
IL13636898A 1997-12-05 1998-12-01 Novel compounds IL136368A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9704546A SE9704546D0 (sv) 1997-12-05 1997-12-05 Novel compounds
PCT/SE1998/002190 WO1999029686A1 (en) 1997-12-05 1998-12-01 Novel compounds

Publications (1)

Publication Number Publication Date
IL136368A0 true IL136368A0 (en) 2001-06-14

Family

ID=20409283

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13636898A IL136368A0 (en) 1997-12-05 1998-12-01 Novel compounds

Country Status (16)

Country Link
EP (1) EP1037889A1 (pt)
JP (1) JP2001525406A (pt)
KR (1) KR20010032800A (pt)
CN (1) CN1284074A (pt)
AU (1) AU1791599A (pt)
BR (1) BR9813378A (pt)
CA (1) CA2312357A1 (pt)
EE (1) EE200000321A (pt)
HU (1) HUP0100731A3 (pt)
IL (1) IL136368A0 (pt)
NO (1) NO20002787L (pt)
PL (1) PL340837A1 (pt)
SE (1) SE9704546D0 (pt)
SK (1) SK8442000A3 (pt)
TR (1) TR200001544T2 (pt)
WO (1) WO1999029686A1 (pt)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9901875D0 (sv) 1999-05-25 1999-05-25 Astra Pharma Prod Novel compounds
SE9904505D0 (sv) 1999-12-09 1999-12-09 Astra Pharma Prod Novel compounds
TWI258462B (en) 1999-12-17 2006-07-21 Astrazeneca Ab Adamantane derivative compounds, process for preparing the same and pharmaceutical composition comprising the same
SE9904652D0 (sv) * 1999-12-17 1999-12-17 Astra Pharma Prod Novel Compounds
JP2002330787A (ja) * 2000-10-21 2002-11-19 Astrazeneca Ab 化学物質
PA8557501A1 (es) 2001-11-12 2003-06-30 Pfizer Prod Inc Benzamida, heteroarilamida y amidas inversas
WO2003042190A1 (en) 2001-11-12 2003-05-22 Pfizer Products Inc. N-alkyl-adamantyl derivatives as p2x7-receptor antagonists
US7071223B1 (en) 2002-12-31 2006-07-04 Pfizer, Inc. Benzamide inhibitors of the P2X7 receptor
PA8591801A1 (es) 2002-12-31 2004-07-26 Pfizer Prod Inc Inhibidores benzamidicos del receptor p2x7.
WO2004099146A1 (en) 2003-05-12 2004-11-18 Pfizer Products Inc. Benzamide inhibitors of the p2x7 receptor
GB0324498D0 (en) 2003-07-21 2003-11-26 Aventis Pharma Inc Heterocyclic compounds as P2X7 ion channel blockers
BRPI0512781A (pt) 2004-06-29 2008-04-08 Pfizer Prod Inc método para preparação de derivados de 5-{4-(2-hidroxi-propil)-3,5-dioxo-4,5-diidro-3h-[1,2,4]tria zin-2-il}-benzamida através da desproteção dos precursores de protetores de hidroxila
JP5306986B2 (ja) 2006-03-16 2013-10-02 エボテック (ユーエス) インコーポレイテッド P2x7調節因子としてのビシクロへテロアリール化合物およびその使用
US8546579B2 (en) 2006-03-16 2013-10-01 Evotec (Us) Inc. Bicycloheteroaryl compounds as P2X7 modulators and uses thereof
TWI464148B (zh) 2006-03-16 2014-12-11 Evotec Us Inc 作為p2x7調節劑之雙環雜芳基化合物與其用途
TW200813018A (en) 2006-06-09 2008-03-16 Astrazeneca Ab Novel compounds
MX2009000117A (es) 2006-07-06 2009-01-23 Glaxo Group Ltd N-fenilmetil-5-oxo-prolin-2-amidas sustituidas como antagonistas de receptores p2x7 y sus metodos de uso.
GB0613473D0 (en) * 2006-07-06 2006-08-16 Glaxo Group Ltd Novel compounds
DK2124562T3 (en) 2007-03-09 2016-08-01 Second Genome Inc BICYCLOHETEROARYLFORBINDELSER AS P2X7 modulators and uses thereof
WO2008116845A1 (en) * 2007-03-28 2008-10-02 Glaxo Group Limited Piperidinone carboxamide derivatives as p2x7 modulators
EP2139875A2 (en) * 2007-03-29 2010-01-06 Glaxo Group Limited Oxazolidine and morpholine carboxamide derivatives as p2x7 modulators
KR20090127435A (ko) 2007-04-03 2009-12-11 글락소 그룹 리미티드 P2x7 조절제로서의 이미다졸리딘 카르복스아미드 유도체
US8119661B2 (en) 2007-09-11 2012-02-21 Astrazeneca Ab Piperidine derivatives and their use as muscarinic receptor modulators
GB0803729D0 (en) * 2008-02-29 2008-04-09 Ge Healthcare Ltd Imaging the central nervous system
ATE494926T1 (de) 2008-03-25 2011-01-15 Affectis Pharmaceuticals Ag Neuartige p2x7r-antagonisten und ihre verwendung
MX2011010810A (es) 2009-04-14 2012-01-12 Affectis Pharmaceuticals Ag Nuevos antagonistas de p2x7r y su uso.
EP2322149A1 (en) 2009-11-03 2011-05-18 Universidad del Pais Vasco Methods and compositions for the treatment of ischemia
EP2386541A1 (en) 2010-05-14 2011-11-16 Affectis Pharmaceuticals AG Novel methods for the preparation of P2X7R antagonists
WO2012110190A1 (en) 2011-02-17 2012-08-23 Affectis Pharmaceuticals Ag Novel p2x7r antagonists and their use
WO2012163792A1 (en) 2011-05-27 2012-12-06 Affectis Pharmaceuticals Ag Novel p2x7r antagonists and their use
WO2012163456A1 (en) 2011-05-27 2012-12-06 Affectis Pharmaceuticals Ag Novel p2x7r antagonists and their use
JP7337083B2 (ja) 2017-11-21 2023-09-01 スリーエム イノベイティブ プロパティズ カンパニー 口腔用植物系水中油型エマルジョン及び使用方法
AU2018392886B2 (en) 2017-12-20 2021-12-23 Solventum Intellectual Properties Company Oral compositions and methods of use
EP3727326A2 (en) 2017-12-20 2020-10-28 3M Innovative Properties Company Oral compositions and methods of use

Also Published As

Publication number Publication date
NO20002787L (no) 2000-08-01
CN1284074A (zh) 2001-02-14
NO20002787D0 (no) 2000-05-31
HUP0100731A3 (en) 2002-08-28
KR20010032800A (ko) 2001-04-25
SK8442000A3 (en) 2001-01-18
BR9813378A (pt) 2000-10-10
JP2001525406A (ja) 2001-12-11
AU1791599A (en) 1999-06-28
TR200001544T2 (tr) 2000-11-21
SE9704546D0 (sv) 1997-12-05
PL340837A1 (en) 2001-02-26
CA2312357A1 (en) 1999-06-17
WO1999029686A1 (en) 1999-06-17
EP1037889A1 (en) 2000-09-27
EE200000321A (et) 2001-08-15
HUP0100731A2 (hu) 2002-05-29

Similar Documents

Publication Publication Date Title
EG24412A (en) Novel compounds
EG24177A (en) Novel compounds
GB9701684D0 (en) Novel compounds
GB9706255D0 (en) Novel compounds
GB9707830D0 (en) Novel compounds
GB9703492D0 (en) Novel compounds
GB9705619D0 (en) Novel compounds
GB9706525D0 (en) Novel compounds
GB9700689D0 (en) Novel compounds
GB9700694D0 (en) Novel compounds
GB9700901D0 (en) Novel compounds
GB9700902D0 (en) Novel compounds
GB9701597D0 (en) Novel compounds
GB9700687D0 (en) Novel compounds
GB9703011D0 (en) Novel compounds
GB9703333D0 (en) Novel compounds
GB9703334D0 (en) Novel compounds
GB9703402D0 (en) Novel compounds
GB9703491D0 (en) Novel compounds
GB9708492D0 (en) Novel compounds
GB9703493D0 (en) Novel compounds
GB9704461D0 (en) Novel compounds
GB9704462D0 (en) Novel compounds
GB9705385D0 (en) Novel compounds
GB9708174D0 (en) Novel compounds